Fund Holdings — Propel Bio Management, LLC

Total Portfolio Value:
$188.62M
Total Bought:
$30.04M
Total Sold:
$37.80M
Net Transaction:
-$7.76M
Notable People:
Leen Kawas, James Francis Harding
Securities
▲▼
SharesValue
Q2 2026
▲▼
Q3 2026
▲▼
Change
▲▼
Q2 2026
▲▼
Q3 2026
▲▼
Weight (%)
▲▼
Change
▲▼
Plains GP Holdings, L.P.COMM(PAGP)1,272,3601,272,3600$30.88M$32.95M17.47%+$2.07M
Achieve Life Sciences IncCOMM4,034,0183,864,148-169,870$26.34M$31.26M16.57%+$4.92M
Delcath Systems IncCOMM871,460604,664-266,796$10.97M$9.66M5.12%-$1.32M
Collegium PharmaceuticalCOMM0410,175+410,175$0$8.95M4.75%+$8.95M
Corcept Therapeutics IncorporatedCOMM(CORT)136,49975,274-61,225$11.87M$8.67M4.60%-$3.19M
Aquestive Therapeutics IncCOMM1,442,397278,723-1,163,674$6.00M$8.61M4.56%+$2.61M
Milestone PharmaceuticalsCOMM7,429,5909,449,727+2,020,137$9.96M$8.18M4.34%-$1.78M
Phathom Pharmaceuticals ICOMM1,050,3581,105,913+55,555$11.40M$8.07M4.28%-$3.32M
COMPASS Pathways plcCOMM(CMPS)573,086549,186-23,900$8.11M$6.83M3.62%-$1.28M
Orchestra Biomed HoldingsCOMM896,701896,7010$3.87M$5.58M2.96%+$1.71M
Maze Therapeutics, Inc.COMM(MAZE)43,798191,998+148,200$1.31M$5.22M2.77%+$3.91M
Abeona Therapeutics IncCOMM983,070956,007-27,063$6.08M$5.02M2.66%-$1.06M
Artiva Biotherapeutics InCOMM696,436696,4360$6.76M$4.96M2.63%-$1.80M
Kyverna Therapeutics IncCOMM883,198700,595-182,603$7.87M$4.76M2.53%-$3.11M
Inventiva Sa - AdrCOMM1,281,2121,133,954-147,258$4.84M$4.18M2.22%-$658.7K
Cabaletta Bio IncCOMM02,049,471+2,049,471$0$3.93M2.09%+$3.93M
Sab Biotherapeutics IncCOMM1,076,5781,187,422+110,844$4.20M$3.76M2.00%-$434.5K
Prokidney CorpCOMM02,009,733+2,009,733$0$3.34M1.77%+$3.34M
Corvus Pharmaceuticals, Inc.COMM(CRVS)70,380264,310+193,930$1.05M$3.04M1.61%+$1.99M
Palisade Bio IncCOMM2,582,3882,224,189-358,199$5.40M$3.00M1.59%-$2.39M
Ocular Therapeutix, Inc.COMM(OCUL)357,966357,9660$3.52M$2.75M1.46%-$769.6K
Scynexis IncCOMM543,478541,474-2,004$2.21M$2.67M1.42%+$462.9K
4d Molecular Therapeutics InCOMM252,654179,154-73,500$3.36M$2.56M1.36%-$796.6K
Ovid Therapeutics IncCOMM1,115,5381,018,721-96,817$3.00M$2.54M1.34%-$464.2K
Immunic IncCOMM325,022236,734-88,288$5.00M$2.20M1.17%-$2.79M
Upstream Bio IncCOMM350,389335,389-15,000$2.42M$1.77M0.94%-$657.2K
Opus Genetics IncCOMM0270,036+270,036$0$1.31M0.69%+$1.31M
Celldex Therapeutics, Inc.COMM(CLDX)103,69537,539-66,156$3.86M$1.22M0.65%-$2.64M
SpyGlass Pharma, Inc.COMM(SGP)041,418+41,418$0$1.08M0.57%+$1.08M
Leonabio IncCOMM149,279149,2790$1.37M$532.9K0.28%-$838.9K
Zevra Therapeutics, Inc.COMM(ZVRA)253,5440-253,544$3.64M$0—-$3.64M
Sagimet Biosciences Inc.COMM(SGMT)125,8780-125,878$973.0K$0—-$973.0K
EyePoint, Inc.COMM(EYPT)191,7450-191,745$2.74M$0—-$2.74M
Silence Therapeutics plcADRS(SLN)191,7330-191,733$2.11M$0—-$2.11M
Page 1 of 1
Propel Bio Management, LLC — 13F Holdings — Q3 2026 | TickerTrail